Assembly bio announces october conference participation

South san francisco, calif., oct. 06, 2021 (globe newswire) -- assembly biosciences, inc. (nasdaq: asmb), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis b virus (hbv), announced participation in the below upcoming conferences focused on hbv:
ASMB Ratings Summary
ASMB Quant Ranking